Alvotech and Teva Report the Regulatory Filing Acceptance for AVT06 (Biosimilar, Eylea) Across the US
Shots: The US FDA has accepted the BLA of AVT06 (2mg) for treating eye disorders,...
Shots: The US FDA has accepted the BLA of AVT06 (2mg) for treating eye disorders,...
Shots: The EC has approved Eydenzelt (CT-P42, aflibercept), a biosimilar to Eylea,...
Shots: The EC has approved SB16: Obodence (60mg pre-filled syring...
Shots: The US FDA has approved Avtozma IV/SC (biosimilar, Actemra) to treat rheuma...
Shots: Dr. Reddy’s & Henlius have entered into a license agreement to de...
Shots: Samsung Bioepis and Teva have signed a development and commerci...
Incisive News in 3 Shots.
Modal body text goes here.